The NCCN 2016 Oncology Nursing Program Webinar Series will provide oncology nurses with comprehensive and clinically relevant information to optimize patient education and care.

Join Ahmet Dogan, MD, PhD and Andrew Zelenetz, MD, PhD from Memorial Sloan Kettering Cancer Center as they present their multidisciplinary expertise on a range of cases pertaining to diffuse large B-cell lymphoma (DLBCL) in Young Adults.

Join Ahmet Dogan, MD, PhD and Andrew Zelenetz, MD, PhD from Memorial Sloan Kettering Cancer Center as they present their multidisciplinary expertise on a range of cases pertaining to diffuse large B-cell lymphoma (DLBCL) in Young Adults.

This information was originally presented at the NCCN 10^th Annual Congress: Hematologic Malignancies™ held in San Francisco, California.

This information was originally presented at the NCCN 10^th Annual Congress: Hematologic Malignancies™ held in San Francisco, California.

This information was originally presented at the NCCN 10^th Annual Congress: Hematologic Malignancies™ held in San Francisco, California.

This information was originally presented at the NCCN 10^th Annual Congress: Hematologic Malignancies™ held in San Francisco, California.

Essential thrombocythemia is well-known to transform to other myeloid disorders, such as leukemia; however, the risk for development of lymphoma is not as well studied.

This information was originally presented on September 20, 2014, at the NCCN 9th Annual Congress: Hematologic Malignancies™ held in New York, New York.

This information was originally presented on September 20, 2014, at the NCCN 9th Annual Congress: Hematologic Malignancies™ held in New York, New York.